218 related articles for article (PubMed ID: 19678474)
1. Understanding chirality and stereochemistry: three-dimensional psychopharmacology.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2009 Jul; 47(7):15-8. PubMed ID: 19678474
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of chirality and stereochemistry in psychopharmacology.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2009 Aug; 47(8):17-21. PubMed ID: 19681517
[TBL] [Abstract][Full Text] [Related]
3. [Chiral switch: pure enantiomers of drugs instead of racemic mixtures].
Valentová J; Hutt AJ
Ceska Slov Farm; 2004 Nov; 53(6):285-93. PubMed ID: 15630994
[TBL] [Abstract][Full Text] [Related]
4. Stereochemistry and drug efficacy and development: relevance of chirality to antidepressant and antipsychotic drugs.
Baker GB; Prior TI
Ann Med; 2002; 34(7-8):537-43. PubMed ID: 12553493
[TBL] [Abstract][Full Text] [Related]
5. Chiral Aspects of Local Anesthetics.
Čižmáriková R; Čižmárik J; Valentová J; Habala L; Markuliak M
Molecules; 2020 Jun; 25(12):. PubMed ID: 32545678
[TBL] [Abstract][Full Text] [Related]
6. Differential properties of enantiomers of commercially available racemates.
Gulati V
J Indian Med Assoc; 2007 Apr; 105(4):173-4, 176. PubMed ID: 17822184
[TBL] [Abstract][Full Text] [Related]
7. Analogues of Anticancer Natural Products: Chiral Aspects.
Valentová J; Lintnerová L; Miklášová N; Oboňová B; Habala L
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982753
[TBL] [Abstract][Full Text] [Related]
8. Single enantiomer drugs: should they be developed?
Khan AY; Preskorn SH; Wimalasena K
Essent Psychopharmacol; 2006; 7(1):15-23. PubMed ID: 16989289
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional view of pharmacology.
Wainer IW
Am J Hosp Pharm; 1992 Sep; 49(9 Suppl 1):S4-8. PubMed ID: 1530004
[TBL] [Abstract][Full Text] [Related]
10. Chirality and its implications in transdermal drug development.
Reddy IK; Kommuru TR; Zaghloul AA; Khan MA
Crit Rev Ther Drug Carrier Syst; 2000; 17(4):285-325. PubMed ID: 10958245
[TBL] [Abstract][Full Text] [Related]
11. The development of single-isomer molecules: why and how.
Hutt AJ
CNS Spectr; 2002 Apr; 7(4 Suppl 1):14-22. PubMed ID: 15131488
[TBL] [Abstract][Full Text] [Related]
12. Racemic mixtures: harmless or potentially toxic?
Ehrlich GE
Am J Hosp Pharm; 1992 Sep; 49(9 Suppl 1):S15-8. PubMed ID: 1530003
[TBL] [Abstract][Full Text] [Related]
13. Putting chirality to work: the strategy of chiral switches.
Agranat I; Caner H; Caldwell J
Nat Rev Drug Discov; 2002 Oct; 1(10):753-68. PubMed ID: 12360254
[TBL] [Abstract][Full Text] [Related]
14. Stereochemistry in clinical medicine: a neurological perspective.
Cordato DJ; Mather LE; Herkes GK
J Clin Neurosci; 2003 Nov; 10(6):649-54. PubMed ID: 14592610
[TBL] [Abstract][Full Text] [Related]
15. The cost benefit ratio of enantiomeric drugs.
Pifferi G; Perucca E
Eur J Drug Metab Pharmacokinet; 1995; 20(1):15-25. PubMed ID: 7588989
[TBL] [Abstract][Full Text] [Related]
16. Stereochemical aspects of pharmacotherapy.
Brocks DR; Jamali F
Pharmacotherapy; 1995; 15(5):551-64. PubMed ID: 8570426
[TBL] [Abstract][Full Text] [Related]
17. Investigation of racemisation of the enantiomers of glitazone drug compounds at different pH using chiral HPLC and chiral CE.
Jamali B; Bjørnsdottir I; Nordfang O; Hansen SH
J Pharm Biomed Anal; 2008 Jan; 46(1):82-7. PubMed ID: 17942259
[TBL] [Abstract][Full Text] [Related]
18. Racemates or enantiomers: regulatory approaches.
Birkett DJ
Clin Exp Pharmacol Physiol; 1989 Jun; 16(6):479-83. PubMed ID: 2670355
[TBL] [Abstract][Full Text] [Related]
19. Stereochemistry in anaesthetic and analgetic drugs.
Mather LE
Minerva Anestesiol; 2005 Sep; 71(9):507-16. PubMed ID: 16166909
[TBL] [Abstract][Full Text] [Related]
20. The real gordian knot: racemic mixtures versus pure enantiomers.
Szelenyi I; Geisslinger G; Polymeropoulos E; Paul W; Herbst M; Brune K
Drug News Perspect; 1998 Apr; 11(3):139-60. PubMed ID: 15616615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
